Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways

Chemoresistance due to heterogeneity of the tumor microenvironment (TME) hampers the long-term efficacy of frontline therapies for lung cancer. Current combination therapies for lung cancer provide only modest improvement in survival, implicating necessity for novel approaches that suppress malignan...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Sawant, Anandi, Schafer, Cara C., Jin, Tong Huan, Zmijewski, Jaroslaw, Tse, Hubert M., Roth, Justin, Sun, Zhihuan, Siegal, Gene P., Thannickal, Victor J., Grant, Stefan C., Ponnazhagan, Selvarangan, Deshane, Jessy S.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854493/
https://ncbi.nlm.nih.gov/pubmed/24085788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0987
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki